These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29879685)

  • 21. A new electronic screening tool for identifying risk of familial hypercholesterolaemia in general practice.
    Troeung L; Arnold-Reed D; Chan She Ping-Delfos W; Watts GF; Pang J; Lugonja M; Bulsara M; Mortley D; James M; Brett T
    Heart; 2016 Jun; 102(11):855-61. PubMed ID: 26864669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
    Wald DS; Wald NJ
    J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of the cost-effectiveness of population genetic screening for familial hypercholesterolemia in US patients.
    Hendy LE; Spees LP; Tak C; Carpenter DM; Thomas KC; Roberts MC
    Atherosclerosis; 2024 Jun; 393():117541. PubMed ID: 38677159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of adjusting LDL-cholesterol for Lp(a)-cholesterol on the diagnosis of familial hypercholesterolaemia.
    Thayabaran D; Tsui APT; Ebmeier S; Cegla J; David A; Jones B
    J Clin Lipidol; 2023; 17(2):244-254. PubMed ID: 36870882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
    Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
    Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-Effectiveness of Screening Algorithms for Familial Hypercholesterolaemia in Primary Care.
    Jones M; Akyea RK; Payne K; Humphries SE; Abdul-Hamid H; Weng S; Qureshi N
    J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Establishing a national screening programme for familial hypercholesterolaemia in Lithuania.
    Petrulioniene Z; Gargalskaite U; Kutkiene S; Staigyte J; Cerkauskiene R; Laucevicius A
    Atherosclerosis; 2018 Oct; 277():407-412. PubMed ID: 30270078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes.
    Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M
    Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparing the performance of the novel FAMCAT algorithms and established case-finding criteria for familial hypercholesterolaemia in primary care.
    Qureshi N; Akyea RK; Dutton B; Leonardi-Bee J; Humphries SE; Weng S; Kai J
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34635577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia.
    Ademi Z; Watts GF; Pang J; Sijbrands EJ; van Bockxmeer FM; O'Leary P; Geelhoed E; Liew D
    J Clin Lipidol; 2014; 8(4):390-400. PubMed ID: 25110220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of familial hypercholesterolemia in patients from a general practice database.
    Casula M; Catapano AL; Rossi Bernardi L; Visconti M; Aronica A
    Atheroscler Suppl; 2017 Oct; 29():25-30. PubMed ID: 28965617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetics and screening of familial hypercholesterolaemia.
    Henderson R; O'Kane M; McGilligan V; Watterson S
    J Biomed Sci; 2016 Apr; 23():39. PubMed ID: 27084339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Population genomic screening of young adults for familial hypercholesterolaemia: a cost-effectiveness analysis.
    Marquina C; Lacaze P; Tiller J; Riaz M; Sturm AC; Nelson MR; Ference BA; Pang J; Watts GF; Nicholls SJ; Zoungas S; Liew D; McNeil J; Ademi Z
    Eur Heart J; 2022 Sep; 43(34):3243-3254. PubMed ID: 34788414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study.
    Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N
    Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the cost-effectiveness equation of cascade testing for familial hypercholesterolaemia.
    Pears R; Griffin M; Futema M; Humphries SE
    Curr Opin Lipidol; 2015 Jun; 26(3):162-8. PubMed ID: 25887683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis of familial hypercholesterolaemia in Western Australia.
    Hooper AJ; Nguyen LT; Burnett JR; Bates TR; Bell DA; Redgrave TG; Watts GF; van Bockxmeer FM
    Atherosclerosis; 2012 Oct; 224(2):430-4. PubMed ID: 22883975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.